Melissa Kotterman founded 4D Molecular Therapeutics, Inc. and Ignite Immunotherapy, Inc. Currently, she holds the position of Vice President-Discovery & Engineering at 4D Molecular Therapeutics, Inc. and Venture Partner at Berkeley Frontier Fund.

Dr. Kotterman received an undergraduate degree from Carnegie Mellon University and a doctorate from UC Berkeley College of Engineering.